LB Pharmaceuticals Inc (LBRX) ROA
- 2026-06-30: ROA -23.69%.
- 2026-03-31: ROA -9.90%.
- 2025-12-31: ROA -8.05%.
- 2025-09-30: ROA -5.86%.
Complete source-backed roa history.
- Available history
- 2024-12-31 to 2026-06-30
- Data captured
Historical ROA
| Date | ROA |
|---|---|
| 2026-06-30 | -23.69% |
| 2026-03-31 | -9.90% |
| 2025-12-31 | -8.05% |
| 2025-09-30 | -5.86% |
| 2024-12-31 | -188.17% |
Annual ROA
| Date | ROA |
|---|---|
| 2025-12-31 | -8.05% |
| 2024-12-31 | -188.17% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |